168 related articles for article (PubMed ID: 31272956)
1. An update on the modern management of paediatric uveitis.
Choi J; Hawley DP; Ashworth J; Edelsten C; Bossuyt ASAM
Br J Ophthalmol; 2019 Dec; 103(12):1685-1689. PubMed ID: 31272956
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in the uveitis of juvenile rheumatoid arthritis.
Wolf MD; Lichter PR; Ragsdale CG
Ophthalmology; 1987 Oct; 94(10):1242-8. PubMed ID: 3684202
[TBL] [Abstract][Full Text] [Related]
3. Update on the Treatment of Uveitis in Patients with Juvenile Idiopathic Arthritis: A Review.
Asproudis I; Katsanos A; Kozeis N; Tantou A; Konstas AG
Adv Ther; 2017 Dec; 34(12):2558-2565. PubMed ID: 29143927
[TBL] [Abstract][Full Text] [Related]
4. [Uveitis in juvenile idiopathic arthritis].
Foeldvari I; Walscheid K; Heiligenhaus A
Z Rheumatol; 2017 Oct; 76(8):664-672. PubMed ID: 28812127
[TBL] [Abstract][Full Text] [Related]
5. Juvenile arthritis-associated uveitis: visual outcomes and prognosis.
Chen CS; Roberton D; Hammerton ME
Can J Ophthalmol; 2004 Oct; 39(6):614-20. PubMed ID: 15559647
[TBL] [Abstract][Full Text] [Related]
6. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.
Angeles-Han ST; Ringold S; Beukelman T; Lovell D; Cuello CA; Becker ML; Colbert RA; Feldman BM; Holland GN; Ferguson PJ; Gewanter H; Guzman J; Horonjeff J; Nigrovic PA; Ombrello MJ; Passo MH; Stoll ML; Rabinovich CE; Sen HN; Schneider R; Halyabar O; Hays K; Shah AA; Sullivan N; Szymanski AM; Turgunbaev M; Turner A; Reston J
Arthritis Care Res (Hoboken); 2019 Jun; 71(6):703-716. PubMed ID: 31021540
[TBL] [Abstract][Full Text] [Related]
7. Risk of Hypotony in Juvenile Idiopathic Arthritis-Associated Uveitis.
Moradi A; Stroh IG; Reddy AK; Hornbeak DM; Leung TG; Burkholder BM; Thorne JE
Am J Ophthalmol; 2016 Sep; 169():113-124. PubMed ID: 27345732
[TBL] [Abstract][Full Text] [Related]
8. Nuclear cataract as an early predictive factor for recalcitrant juvenile idiopathic arthritis-associated uveitis.
Suelves AM; Lamba N; Meese HK; Foster CS; González-Martín JM; Díaz-Llopis M; Christen WG
J AAPOS; 2016 Jun; 20(3):232-238.e1. PubMed ID: 27164426
[TBL] [Abstract][Full Text] [Related]
9. [Clinical features and therapy of uveitis in childhood].
Kiss J; Gaál V; Nyul Z; Mosdósi B
Orv Hetil; 2019 Aug; 160(34):1335-1339. PubMed ID: 31423830
[TBL] [Abstract][Full Text] [Related]
10. Juvenile idiopathic arthritis-associated uveitis.
Sen ES; Ramanan AV
Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):517-534. PubMed ID: 29773271
[TBL] [Abstract][Full Text] [Related]
11. Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
Tappeiner C; Mesquida M; Adán A; Anton J; Ramanan AV; Carreno E; Mackensen F; Kotaniemi K; de Boer JH; Bou R; de Vicuña CG; Heiligenhaus A
J Rheumatol; 2016 Dec; 43(12):2183-2188. PubMed ID: 27633821
[TBL] [Abstract][Full Text] [Related]
12. Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST-Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial.
Acharya NR; Ebert CD; Kelly NK; Porco TC; Ramanan AV; Arnold BF;
Trials; 2020 Oct; 21(1):887. PubMed ID: 33109240
[TBL] [Abstract][Full Text] [Related]
13. Presentation of suspected pediatric uveitis.
Saeed MU; Raza SH; Goyal S; Cleary G; Newman WD; Chandna A
Semin Ophthalmol; 2014 Jan; 29(1):4-7. PubMed ID: 23952132
[TBL] [Abstract][Full Text] [Related]
14. Infliximab for juvenile idiopathic arthritis-associated uveitis.
Richards JC; Tay-Kearney ML; Murray K; Manners P
Clin Exp Ophthalmol; 2005 Oct; 33(5):461-8. PubMed ID: 16181269
[TBL] [Abstract][Full Text] [Related]
15. Ocular threat in juvenile idiopathic arthritis.
Marvillet I; Terrada C; Quartier P; Quoc EB; Bodaghi B; Prieur AM
Joint Bone Spine; 2009 Jul; 76(4):383-8. PubMed ID: 19524473
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate for resistant chronic uveitis in children with juvenile rheumatoid arthritis.
Weiss AH; Wallace CA; Sherry DD
J Pediatr; 1998 Aug; 133(2):266-8. PubMed ID: 9709718
[TBL] [Abstract][Full Text] [Related]
17. Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis.
Birolo C; Zannin ME; Arsenyeva S; Cimaz R; Miserocchi E; Dubko M; Deslandre CJ; Falcini F; Alessio M; La Torre F; Denisova E; Martini G; Nikishina I; Zulian F
J Rheumatol; 2016 Nov; 43(11):2068-2073. PubMed ID: 27633826
[TBL] [Abstract][Full Text] [Related]
18. Temporal change in prevalence and complications of uveitis associated with juvenile idiopathic arthritis:data from a cross-sectional analysis of a prospective nationwide study.
Tappeiner C; Klotsche J; Schenck S; Niewerth M; Minden K; Heiligenhaus A
Clin Exp Rheumatol; 2015; 33(6):936-44. PubMed ID: 26517055
[TBL] [Abstract][Full Text] [Related]
19. Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated with Juvenile Idiopathic Arthritis.
Cecchin V; Zannin ME; Ferrari D; Pontikaki I; Miserocchi E; Paroli MP; Bracaglia C; Marafon DP; Pastore S; Parentin F; Simonini G; De Libero C; Falcini F; Petaccia A; Filocamo G; De Marco R; La Torre F; Guerriero S; Martino S; Comacchio F; Muratore V; Martini G; Vittadello F; Zulian F
J Rheumatol; 2018 Aug; 45(8):1167-1172. PubMed ID: 29657140
[TBL] [Abstract][Full Text] [Related]
20. Juvenile idiopathic arthritis associated uveitis in adults: a case series.
Camuglia JE; Whitford CL; Hall AJ
Ocul Immunol Inflamm; 2009; 17(5):330-4. PubMed ID: 19831566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
